Retatrutide raw material with 99% purity - Factory direct sales with large discounts
7470 Inquiries
2381089-83-2
Pharmaceutical Grade
99%
Hong Kong
Duole
5mg 10mg 15mg 20mg 30mg 50/60mg per vial; 10vials/box
Yes
2026-08-16
Tirzepatide,Retatrutide,Semaglutide
-
Product Details
-
Seller Information
-
Inquiry History
-
DescriptionECHEMI Editorial ReferenceRetatrutide is a novel triple agonist peptide of the glucagon receptor (GCGR), glucose-dependent insulinotropic polypeptide receptor (GIPR) and glucagon-like peptide-1 receptor (GLP-1R). Retatrutide inhibits human GCGR, GIPR and GLP-1R with EC50 values of 5.79, 0.0643 and 0.775 nM, respectively and mouse GCGR, GIPR, and GLP-1R with EC50 values of 2.32, 0.191 and 0.794 nM, respectively. It is an important tool for obesity research.Retatrutide potently activates the GLP-1R signaling pathway to stimulate glucose-dependent insulin secretion through activity at the GIP receptor (GIPR) or the GLP-1R.Retatrutide is a synthetic peptide with glucose-lowering effects. It is an antidiabetic agent against type 2 diabetes (T2D), stimulating insulin and suppressing glucagon secretion in a glucose-dependent manner.Retatrutide was also shown to delay gastric emptying, lower fasting and postprandial glucose concentration, decrease food intake and reduce body weight in patients with type 2 diabetes.
Retatrutide (LY-3437943) was discovered by the American pharmaceutical company Eli Lilly and Company. It is a triple glucagon hormone receptor agonist (GLP-1, GIP, and GCGR receptors) for obesity. The 2024 Lasker~DeBakey Clinical Medical Research Award has been given to Joel Habener and Svetlana Mojsov for their discovery of a new hormone GLP-1(7-37) and to Lotte Knudsen for her role in developing sustained acting versions of this hormone as a treatment for obesity.Basic Info-
Product Name:
Retatrutide
Other Name:Retatrutide;GIPR/GLP-1R;LY3437943Retatrutide;Retalutide;Retatrutide (sodium salt);Retatrutide RT5;retatrutide 5mg;Retatratide
CAS No.:2381089-83-2
InChIKeys:MLOLQJNKXBNWFW-SAGGEDDASA-N
Molecular Weight:0
EC Number:200-001-8
Color/Form:White lyophilized
Categories:
Characteristics-
Water Solubility:
Soluble in water (5mg/ml).
Storage Conditions:-20°C
Critical Temperature & Pressure:-20°C
Research-
Class:
Triple agonist — GCGR, GIPR, GLP-1R
Status:Investigational (Phase 3)
Mechanism:Simultaneously activates glucagon receptor (GCGR), glucose-dependent insulinotropic polypeptide receptor (GIPR), and glucagon-like peptide-1 receptor (GLP-1R). Engineered from the native GIP backbone with amino acid substitutions to confer GCGR and GLP-1R activity.
EC50 (Human GCGR):5.79 nM
EC50 (Mouse GIPR):0.191 nM
EC50 (Mouse GLP1R):0.794 nM
EC50 (Mouse GCGR):2.32 nM
EC50 (Human GLP1R):0.775 nM
EC50 (Human GIPR):0.0643 nM
Source:Jastreboff AM, et al. N Engl J Med. 2023;389(6):514-526.DOI
Clinical Development:
References-
ChEMBL:DrugBank:KEGG DRUG:PubChem:Disclaimer:
Retatrutide is an investigational compound not yet approved by FDA or EMA. This listing is for industrial and laboratory research use only. Product information on ECHEMI is provided for sourcing and specification reference. It is not medical advice, a clinical recommendation, or an approved therapy description. Always verify regulatory status, purity, and intended use with the supplier and applicable authorities before purchase or use.
-
-
Seller Information
-
Business Type:
Trader
-
Main Products:
Tirzepatide,Retatrutide,Semaglutide
-
Location:
Room 1811-A096, Jingu Building, No.319 Jinxing Middle Road, Xihu Street, Yuelu District, Changsha City, Hunan Province
-
Payment Terms:
TT against copy of documents
-
Average lead Time:
2 days
-
Total Annual Revenue:
$1 million-$2.5 million
-
Total Employees:
11-50
-
Year of Establishment:
2023
-
-
Inquiry History7470 Inquiries
Country Product Purchase Quantity Date Posted
United States
Retatrutide
100 PCS Oct 27, 2026
New Zealand
Retatrutide
20 PCS Oct 27, 2026
Netherlands
Retatrutide
100 20' Fcl Oct 27, 2026
United States
Retatrutide
300 MG Oct 27, 2026
Canada
Retatrutide
1 G Oct 26, 2026
Switzerland
Retatrutide
1 KG Oct 26, 2026
United States
Retatrutide
10 MG Oct 26, 2026
Australia
Retatrutide
30 MG Oct 26, 2026
United States
Retatrutide
30 MG Oct 26, 2026
United States
Tesa
2 MG Oct 25, 2026
Colombia
Retatrutide
15 MG Oct 25, 2026
United States
Retatrutide
10 G Oct 25, 2026
Canada
Retatrutide
1 KG Oct 25, 2026
United Kingdom
Retatrutide
1 G Oct 25, 2026
Netherlands
Retatrutide
10 MG Oct 25, 2026
Australia
Retatrutide
10 MG Oct 25, 2026
Netherlands
Retatrutide
20 MG Oct 25, 2026
Germany
Retatrutide
1 KG Oct 25, 2026
United Kingdom
Retatrutide
10 G Oct 25, 2026
United States
Retatrutide
20 MG Oct 25, 2026 Post an enquiry for this product
More from this Seller
-
-
-
Low Price CJC no DAC 5mgFreeze-Dried Powder Worldwide Shipping Factory direct sales, available in stock
Pharmaceutical Grade / 99%
$100-110/UNIT FOB
-
-
-
-
Semaglutide tirzepatide retatrutide Raw material wholesale Pharmaceutical grade
Pharmaceutical Grade / 99%
-
-
-
-
China factory High Quality Pure 99% Peptide NA-931 bioglutide, Tirzepatide, semaglutide and retatrutide
Pharmaceutical Grade / 99%
-
-
-
-
A kit of Liraglutide Liraglutide Peptides in Vials 5mg 10mg 15mg Factory Supply Support customization
Pharmaceutical Grade / 99%
-
-
-
-
Weight Managemet Raw Survodutide Retatrutide Tirzepatide Powder Peptide Fast delivery
Pharmaceutical Grade / 99%
$100-110/UNIT FOB
-
-
-
-
Safety and fast delivery high quality 5-amino-1 tirzepatide with good factory price
Pharmaceutical Grade / 99%
-